Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. May 15, 2025; 17(5): 106103
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.106103
Table 1 Clinical information of patients in the training and validation sets
Variable
Training set (n = 220)
Validation set (n = 95)
t-test/Z/χ2 value
P value
Sex1.92230.166
F9031
M13064
Age2.95130.229
≤ 50 years247
51-65 years10941
> 65 years8747
pT stage5.82730.120
T151
T24129
T315055
T42410
pN stage2.93330.231
N06236
N17126
N28733
TP65.14 (61.60, 69.66)65.30 (61.60)-0.37520.707
ALB38.55 (35.95, 41.65)38.40 (36.02, 40.97)-0.60920.543
ALP76.00 (61.27, 89.00)76.00 (65.20, 88.00)-0.73620.462
UREA5.33 (4.46, 6.43)5.48 (4.35, 6.46)-0.45620.649
CREA62.50 (53.53, 71.03)64.40 (56.00, 72.50)-1.28120.200
UA269.73 (229.00, 331.75)265.00 (221.00, 314.00)-0.85120.395
TC, mean ± SD4.11 ± 2.477.22 ± 31.31-1.46910.143
TG1.18 (0.93, 1.53)1.25 (0.92, 1.60)-0.60020.549
HDL-C0.95 (0.83, 1.11)0.97 (0.79, 1.15)-0.23820.812
LDL-C2.32 (1.90, 2.82)2.41 (1.77, 2.94)-0.04220.967
FBG2.96 (2.16, 3.57)3.02 (2.52, 3.71)-0.96420.335
D-dimer2.02 (0.75, 3.27)2.13 (0.93, 3.23)-0.50520.614
WBC5.75 (4.70, 7.10)5.70 (4.70, 7.00)-0.21820.828
NEUT3.26 (2.49, 4.48)3.29 (2.54, 4.59)-0.00420.997
Lym1.67 (1.14, 2.11)1.59 (1.16, 2.07)-0.41820.676
M0.46 (0.34, 0.56)0.45 (0.37, 0.54)-0.15820.875
E0.10 (0.06, 0.17)0.11 (0.06, 0.18)-0.02020.984
B0.03 (0.02, 0.04)0.02 (0.01, 0.04)-1.35320.176
RBC4.38 (3.96, 4.80)4.46 (4.06, 4.81)-0.44620.656
HB132.00 (117.25, 147.00)134.00 (121.00, 146.00)-0.73420.463
PLT208.00 (167.25, 251.00)204.00 (163.00, 248.00)-0.29420.769
BMI23.05 (20.82, 24.68)22.61 (20.81, 24.61)-0.57220.568